Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
35.44    1.20 (3.50%)
Bid:
35.44
Ask:
35.52
Spread: 0.08 (0.226%)
Market Cap: £566.69m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Board Changes

16 Jan 2025 07:00

RNS Number : 4829T
Hays PLC
16 January 2025
 

16 January 2025

 

HAYS PLC

BOARD CHANGES

Hays plc ("Hays") today announces the appointment of Michael Findlay to its Board as a Non-Executive Director and Chair-designate. He will join the Board on 20 January 2025 and will succeed Andrew Martin as Non-Executive Chair from 1 May 2025. Andrew will retire on 1 May 2025 after nearly 8 years on the Board.

Michael Findlay is currently Non-Executive Chair of London Stock Exchange plc and a Non-Executive Director of International Distribution Services plc and Jarrold & Sons Limited. Michael is also Chair of Morgan Sindall Group plc but announced yesterday that he will be stepping down from the Board on 28 July 2025. Previous roles include co-head of investment banking for UK and Ireland at Bank of America and Senior Independent Director at UK Mail Group plc.

Cheryl Millington, Hays' Senior Independent Director, who led the succession process, said: "I am delighted that Michael will be joining the Hays Board. Michael is a highly accomplished business leader and a proven Non-Executive and Chair. Having spent his executive career in corporate broking and investment banking, Michael has advised many leading UK plcs on a wide range of strategic, financing and governance matters. He also brings a strong understanding of people intensive and service orientated businesses."

"I also want to take this opportunity to thank Andy on behalf of the Board for his exemplary leadership, during a period of significant change for the Group, and wish him all the very best for the future."

Michael said: "I am delighted to be joining Hays and I look forward to working with the Board and the executive team to drive forward the Group's strategy to create significant value for all stakeholders."

Andy Martin commented: "It has been a privilege to serve on the Board of Hays for nearly 8 years. It is a great company and I wish all of the incredible team every success for the future, and wish Michael all the very best as he leads the Board on this next important step of the Hays journey."

This announcement is made in accordance with Listing Rule 6.4.6. There are no further matters to be disclosed under Listing Rule 6.4.8.

 

Enquiries

Hays plc

Rachel FordKean Marden

FGS GlobalGuy Lamming / Anjali Unnikrishnan / Richard Crowley

 

General Counsel & Company Secretary

Head of Investor Relations & ESG

 

+44 (0) 333 010 2682

+44 (0) 333 010 7092hays@fgsglobal.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVANRVAUAAAR
Date   Source Headline
2nd Apr 20207:00 amRNSTrading Update & Equity Placing
1st Apr 202010:00 amRNSTotal Voting Rights
9th Mar 202010:12 amRNSDirector/PDMR Shareholding
4th Mar 20204:40 pmRNSHolding(s) in Company
2nd Mar 202010:00 amRNSTotal Voting Rights
20th Feb 20207:00 amRNSHalf-year Report
12th Feb 202012:09 pmRNSBlock listing Interim Review
3rd Feb 202010:00 amRNSTotal Voting Rights
16th Jan 20207:00 amRNSSecond Quarter Trading Update
6th Jan 20202:43 pmRNSDirector Declaration
2nd Jan 202010:00 amRNSTotal Voting Rights
17th Dec 20194:50 pmRNSHolding(s) in Company
2nd Dec 201910:00 amRNSTotal Voting Rights
13th Nov 20193:49 pmRNSResult of AGM
1st Nov 201910:00 amRNSTotal Voting Rights
29th Oct 20199:40 amRNSDirector/PDMR Shareholding
15th Oct 20197:00 amRNSFirst Quarter Trading Update
1st Oct 20192:22 pmRNSDirector/PDMR Shareholding
1st Oct 201910:12 amRNSDirector/PDMR Shareholding
1st Oct 201910:00 amRNSTotal Voting Rights
30th Sep 20194:27 pmRNSAnnual Financial Report
13th Sep 20193:21 pmRNSDirector/PDMR Shareholding
12th Sep 201912:37 pmRNSDirector/PDMR Shareholding
9th Sep 20193:10 pmRNSDirector/PDMR Shareholding
6th Sep 201910:47 amRNSDirector/PDMR Shareholding
5th Sep 201910:00 amRNSBlock Listing Application
2nd Sep 201910:00 amRNSTotal Voting Rights
30th Aug 201910:27 amRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSFinal Results
1st Aug 201910:00 amRNSTotal Voting Rights
16th Jul 20197:00 amRNSFinal Quarter Trading Update
11th Jul 201910:16 amRNSDirector/PDMR Shareholding
10th Jul 20199:08 amRNSHolding(s) in Company
1st Jul 201910:00 amRNSTotal Voting Rights
17th Jun 20199:00 amRNSDirectorate Change
3rd Jun 201910:00 amRNSTotal Voting Rights
20th May 20198:30 amRNSDirector Declaration
7th May 201910:00 amRNSChange of Registered Office
1st May 201910:00 amRNSTotal Voting Rights
26th Apr 20193:54 pmRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSThird Quarter Trading Update
1st Apr 201910:00 amRNSTotal Voting Rights
28th Mar 201910:21 amRNSDirector/PDMR Shareholding
13th Mar 20193:08 pmRNSDirector/PDMR Shareholding
12th Mar 201912:05 pmRNSDirector/PDMR Shareholding
1st Mar 201910:00 amRNSTotal Voting Rights
27th Feb 20193:22 pmRNSDirector Declaration
21st Feb 20197:00 amRNSHalf-year Report
20th Feb 20198:30 amRNSDirectorate Change
13th Feb 20193:30 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.